Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves: Experimental Physiology-Research Paper

Experimental Physiology

Volumn 95, Issue 2, 2010, Pages 304-314

  Parrish, Diana C ^a   Alston, Eric N ^a   Rohrer, Hermann ^b   Nkadi, Paul ^a   Woodward, William R ^a   Schütz, Günther ^c   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOBUTAMINE; DOPAMINE BETA MONOOXYGENASE; GLYCOPROTEIN GP 130; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GANGLION BLOCK; GENE DELETION; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART NERVE; HEART STIMULATION; HORMONE TRANSPORT; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WILD TYPE;

EID: 75149171019     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.049965     Document Type: Article

References (42)

1. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, Yui Y Sasayama S (2000). Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 32, 1821 1830.
2. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, Kubler W Haass M (2001). The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol 33, 461 472.
3. Barber MJ, Mueller TM, Henry DP, Felten SY Zipes DP (1983). Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67, 787 796.
4. 2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96, 1914 1922.
5. Boulton TG, Zhong Z, Wen Z, Darnell JEJ, Stahl N Yancopoulos GD (1995). STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci USA 92, 6915 6919.
6. Brar BK, Stephanou A, Liao Z, O'Leary RM, Pennica D, Yellon DM Latchman DS (2001). Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res 51, 265 274.
7. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC Chen PS (2000a). Nerve sprouting and sudden cardiac death. Circ Res 86, 816 821.
8. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS Chen LS (2000b). Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101, 1960 1969.
9. Cervini R, Berrard S, Bejanin S Mallet J (1994). Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters. NeuroReport 5, 1346 1348.
10. Cheng JG, Pennica D Patterson PH (1997). Cardiotrophin-1 induces the same neuropeptides in sympathetic neurons as do neuropoietic cytokines. J Neurochem 69, 2278 2284.
11. Dae MW, Lee RJ, Ursell PC, Chin MC, Stillson CA Moise NS (1997). Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation 96, 1337 1342.
12. Du XJ, Cox HS, Dart AM Esler MD (1999). Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res 43, 919 929.
13. Dziennis S Habecker BA (2003). Cytokine suppression of dopamine-β-hydroxylase by extracellular signal-regulated kinase-dependent and-independent pathways. J Biol Chem 278, 15897 15904.
14. Frangogiannis NG, Smith CW Entman ML (2002). The inflammatory response in myocardial infarction. Cardiovasc Res 53, 31 47.
15. Gritman K, Van Winkle DM, Lorentz CU, Pennica D Habecker BA (2006). The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine 36, 9 16.
16. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH Entman ML (1999). Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546 551.
17. Habecker BA, Klein MG, Sundgren NC, Li W Woodward WR (2002). Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin. J Neurosci 22, 9445 9452.
18. Habecker BA, Sachs HH, Rohrer H Zigmond RE (2009). The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons. Dev Neurobiol 69, 392 400.
19. Haverkamp W, Hindricks G Gülker H (1990). Antiarrhythmic properties of beta-blockers. J Cardiovasc Pharmacol 16 (Suppl 5 S29 S32.
20. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F Graeve L (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334, 297 314.
21. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr., Muller W Chien KR (1999). Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189 198.
22. Kreusser MM, Buss SJ, Krebs J, Kinscherf R, Metz J, Katus HA, Haass M Backs J (2008). Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart. J Mol Cell Cardiol 44, 380 387.
23. Kristen AV, Kreusser MM, Lehmann L, Kinscherf R, Katus HA, Haass M Backs J (2006). Preserved norepinephrine reuptake but reduced sympathetic nerve endings in hypertrophic volume-overloaded rat hearts. J Card Fail 12, 577 583.
24. Kumer SC Vrana KE (1996). Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67, 443 462.
25. Lewis SE, Rao MS, Symes AJ, Dauer WT, Fink JS, Landis SC Hyman SE (1994). Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. J Neurochem 63, 429 438.
26. Li W, Knowlton D, Van Winkle DM Habecker BA (2004). Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am J Physiol Heart Circ Physiol 286, H2229 H2236.
27. Li W, Knowlton D, Woodward WR Habecker BA (2003). Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 86, 774 783.
28. Liang CS, Fan TH, Sullebarger JT Sakamoto S (1989). Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to β-adrenoceptor downregulation. J Clin Invest 84, 1267 1275.
29. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P Torp-Pedersen C (2004). Expert consensus document on β-adrenergic receptor blockers. Eur Heart J 25, 1341 1362.
30. Parrish DC, Alston EN, Rohrer H, Hermes SM, Aicher SA, Nkadi P, Woodward WR, Stubbusch J, Gardner RT Habecker BA (2009). The absence of gp130 in dopamine β-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias. Am J Physiol Heart Circ Physiol 297, H960 H967.
31. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M Habecker BA (2008). Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 294, H99 H106.
32. Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P Landis SC (1993). Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11, 1175 1185.
33. Raynaud B, Faucon-Biguet N, Vidal S, Mallet J Weber MJ (1987). The use of a tyrosine-hydroxylase cDNA probe to study the neurotransmitter plasticity of rat sympathetic neurons in culture. Dev Biol 119, 305 312.
34. Rubart M Zipes DP (2005). Mechanisms of sudden cardiac death. J Clin Invest 115, 2305 2315.
35. Sharma VK Banerjee SP (1977). Inhibition of [3H]norepinephrine uptake in peripheral organs of some mammalian species by ouabain. Eur J Pharmacol 41, 417 429.
36. Shi X Habecker BA (2009). Gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase in sympathetic neurons. FASEB J 23, 576.
37. Stanke M, Duong CV, Pape M, Geissen M, Burbach G, Deller T, Gascan H, Otto C, Parlato R, Schutz G Rohrer H (2006). Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 133, 141 150.
38. Taga T (1996). gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J Neurochem 67, 1 10.
39. Vrana KE, Allhiser CL Roskoski RJ (1981). Tyrosine hydroxylase activation and inactivation by protein phosphorylation conditions. J Neurochem 36, 92 100.
40. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N Kishimoto T (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93, 407 411.
41. Zipes DP (1990). Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82, 1095 1105.
42. Zou Y, Takano H, Mizukami M, Akazawa H, Qin Y, Toko H, Sakamoto M, Minamino T, Nagai T Komuro I (2003). Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108, 748 753.